References
- Bilezikian JP, Bandeira L, Khan A, et al. Hyperparathyroidism. Lancet. 2018;391(10116):168–178.
- Machado NN, Wilhelm SM. Diagnosis and evaluation of primary hyperparathyroidism. Surg Clin North Am. 2019;99(4):649–666.
- Minisola S, Gianotti L, Bhadada S, et al. Classical complications of primary hyperparathyroidism. Best Pract Res Clin Endocrinol Metab. 2018;32(6):791–803.
- Walker MD, Silverberg SJ. Cardiovascular aspects of primary hyperparathyroidism. J Endocrinol Invest. 2008;31(10):925–931.
- Lind L, Hvarfner A, Palmer M, et al. Hypertension in primary hyperparathyroidism in relation to histopathology. Eur J Surg. 1991;157(8):457–459.
- Vestergaard P. Primary hyperparathyroidism and nephrolithiasis. Ann Endocrinol (Paris). 2015;76(2):116–119.
- Peacock M. Primary hyperparathyroidism and the kidney: biochemical and clinical spectrum. J Bone Miner Res. 2002;17 (Suppl 2):N87–94.
- Mazzuoli GF, D’Erasmo E, Pisani D. Primary hyperparathyroidism and osteoporosis. Aging Clin Exp Res). 1998;10(3):225–231.
- Makras P, Anastasilakis AD. Bone disease in primary hyperparathyroidism. Metabolism. 2018;80:57–65.
- Ejlsmark-Svensson H, Bislev LS, Lajlev S, et al. Prevalence and risk of vertebral fractures in primary hyperparathyroidism: a nested case-control study. J Bone Miner Res. 2018;33(9):1657–1664.
- Misiorowski W, Czajka-Oraniec I, Kochman M, et al. Osteitis fibrosa cystica-a forgotten radiological feature of primary hyperparathyroidism. Endocrine. 2017;58(2):380–385.
- Nilsson IL. Primary hyperparathyroidism: should surgery be performed on all patients? Current evidence and residual uncertainties. J Intern Med. 2019;285(2):149–164.
- Egan RJ, Scott-Coombes DM. The surgical management of sporadic primary hyperparathyroidism. Best Pract Res Clin Endocrinol Metab. 2018;32(6):847–859.
- Strom C, Rasmussen LS, Sieber FE. Should general anaesthesia be avoided in the elderly? Anaesthesia. 2014;69 (Suppl 1):35–44.
- Katz SC, Wang GJ, Kramer EL, et al. Limitations of technetium 99m sestamibi scintigraphic localization for primary hyperparathyroidism associated with multiglandular disease. Am Surg. 2003;69(2):170–175.
- Head HW, Dodd GD, III. Thermal ablation for hepatocellular carcinoma. Gastroenterology. 2004;127(5):S167–S78.
- Ben Hamou A, Ghanassia E, Espiard S, et al. Safety and efficacy of thermal ablation (radiofrequency and laser): should we treat all types of thyroid nodules? Int J Hyperthermia. 2019;36(1):666–676.
- Sanchez A, Feldman AS, Hakimi AA. Current management of small renal masses, including patient selection, renal tumor biopsy, active surveillance, and thermal ablation. JCO. 2018;36(36):3591–3600.
- Dobnig H, Amrein K. Value of monopolar and bipolar radiofrequency ablation for the treatment of benign thyroid nodules. Best Pract Res Clin Endocrinol Metab. 2019;33(4):1–15.
- Ruiter SJS, Heerink WJ, de Jong KP. Liver microwave ablation: a systematic review of various FDA-approved systems. Eur Radiol. 2019;29(8):4026–4035.
- de Senneville BD, Moonen C, Ries M. MRI-guided HIFU methods for the ablation of liver and renal cancers. Adv Exp Med Biol. 2016;880:43–63.
- Ha EJ, Baek JH, Kim KW, et al. Comparative efficacy of radiofrequency and laser ablation for the treatment of benign thyroid nodules: systematic review including traditional pooling and bayesian network meta-analysis. J Clin Endocrinol Metab. 2015;100(5):1903–1911.
- Feng B, Liang P. Local thermal ablation of renal cell carcinoma. Eur J Radiol. 2012;81(3):437–440.
- Bennedbaek FN, Karstrup S, Hegedüs L. Ultrasound guided laser ablation of a parathyroid adenoma. BJR. 2001;74(886):905–907.
- Andrioli M, Riganti F, Pacella CM, et al. Long-term effectiveness of ultrasound-guided laser ablation of hyperfunctioning parathyroid adenomas: present and future perspectives. Am J Roentgenol. 2012;199(5):1164–1168.
- Jiang TA, Chen F, Zhou X, et al. Percutaneous ultrasound-guided laser ablation with contrast-enhanced ultrasonography for hyperfunctioning parathyroid adenoma: a preliminary case series. Int J Endocrinol. 2015;2015:1–6.
- Liu C, Wu B, Huang PT, et al. US-guided percutaneous microwave ablation for primary hyperparathyroidism with parathyroid nodules: feasibility and safety study. J Vasc Intervent Radiol. 2016;27(6):867–875.
- Yu MA, Yao L, Zhang L, et al. Safety and efficiency of microwave ablation for recurrent and persistent secondary hyperparathyroidism after parathyroidectomy: a retrospective pilot study. Int J Hyperthermia. 2016;32(2):180–186.
- Sormaz IC, Poyanli A, Acar S, et al. CASE SERIES The Results of Ultrasonography-Guided Percutaneous Radiofrequency Ablation in Hyperparathyroid Patients in Whom Surgery Is Not Feasible. Cardiovasc Intervent Radiol. 2017;40(4):596–602.
- Wang G, Liu S, Liu X, et al. Microwave ablation: an effective treatment for mild-to-moderate secondary hyperparathyroidism in patients undergoing haemodialysis. Int J Hyperthermia. 2017;33(8):946–952.
- Zhuo L, Peng LL, Zhang YM, et al. US-guided microwave ablation of hyperplastic parathyroid glands: safety and efficacy in patients with end-stage renal disease-a pilot study. Radiology. 2017;282(2):576–584.
- Knobloch K, Yoon U, Vogt PM. Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias. J Craniomaxillofac Surg. 2011;39(2):91–92.
- Sacks D, McClenny TE, Cardella JF, et al. Society of Interventional Radiology clinical practice guidelines. J Vasc Intervent Radiol. 2003;14(9):S199–S202.
- Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383–394.
- Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988. p. 1–17.
- Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560.
- Zwahlen M, Renehan A, Egger M. Meta-analysis in medical research: potentials and limitations. Urol Oncol. 2008;26(3):320–329.
- Borenstein M, Hedges LV, Higgins JP, et al. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Method. 2010;1(2):97–111.
- Copas J, Shi JQ. Meta-analysis, funnel plots and sensitivity analysis. Biostatistics. 2000;1(3):247–262.
- Egger M, Smith GD, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634.
- Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Statist Med. 2006;25(20):3443–3457.
- Kovatcheva R, Vlahov J, Stoinov J, et al. US-guided high-intensity focused ultrasound as a promising non-invasive method for treatment of primary hyperparathyroidism. Eur Radiol. 2014;24(9):2052–2058.
- Fan BQ, He XW, Chen HH, et al. US-guided microwave ablation for primary hyperparathyroidism: a safety and efficacy study. Eur Radiol. 2019;29(10):5607–5616.
- Liu F, Yu X, Liu Z, et al. Comparison of ultrasound-guided percutaneous microwave ablation and parathyroidectomy for primary hyperparathyroidism. Int J Hyperther. 2019;36(1):835–840.
- Bilezikian JP. Primary Hyperparathyroidism. J Clin Endocrinol Metab. 2018;103(11):3993–4004.
- Insogna KL. Primary Hyperparathyroidism. N Engl J Med. 2018;379(11):1050–1059.
- Regier M, Chun F. Thermal ablation of renal tumors: indications, techniques and results. Dtsch Arztebl Int. 2015;112(24):412–418.
- Vogl TJ, Farshid P, Naguib NN, et al. Thermal ablation of liver metastases from colorectal cancer: radiofrequency, microwave and laser ablation therapies. Radiol Med. 2014;119(7):451–461.
- Yin XY, Xie XY, Lu MD, et al. Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors. Cancer. 2009;115(9):1914–1923.
- Trimboli P, Castellana M, Sconfienza LM, et al. Efficacy of thermal ablation in benign non-functioning solid thyroid nodule: a systematic review and meta-analysis. Endocrine. 2020;67(1):35–43.
- Mauri G, Cova L, Monaco CG, et al. Benign thyroid nodules treatment using percutaneous laser ablation (PLA) and radiofrequency ablation (RFA). Int J Hyperthermia. 2017;33(3):295–299.
- Chung SR, Suh CH, Baek JH, et al. Safety of radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: a systematic review and meta-analysis. Int J Hyperthermia. 2017;33(8):920–930.
- Gong L, Tang W, Lu J, et al. Thermal ablation versus parathyroidectomy for secondary hyperparathyroidism: a meta-analysis. Int J Surg. 2019;70:13–18.